ACE and hydrops fetalis: Only 61.1% had filled their prescriptions for an HF beta-blocker plus an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker at least once during the 90 days before ICD implantation, and only 28.3% had a supply for ≥ 80% of the 90 days.